Recently, magAssist’s NyokAssist™ Interventional Ventricular Assist Device, has been granted designation as a breakthrough device by the U.S. Food and Drug Administration in Breakthrough Device Program.
Recently, magAssist’s NyokAssist™ Interventional Ventricular Assist Device, has been granted designation as a breakthrough device by the U.S. Food and Drug Administration in Breakthrough Device Program.